Document text
Principal Investigator: Jonathan D Posner
Organization: UNIVERSITY OF WASHINGTON
Fiscal Year: 2020
Award: $413,677
Funding agency: National Institute of Biomedical Imaging and Bioengineering
ABSTRACT
COVID-19 is a severe respiratory tract infection caused by the newly discovered, and highly contagious, SARS-
CoV-2 virus that emerged in late 2019 in Wuhan, China and has infected over 3 million people globally (> 1M
US) and has caused over 215,000 deaths (58,000 US). SARS-CoV-2 RNA is the only sensitive and specific
biomarker for diagnosis of an active COVID-19 infection and is diagnosed by reverse-transcription polymerase
chain reaction (RT-PCR) in a central virology lab. Several CLIA-waived NAAT systems have been rapidly
adapted for testing COVID-19, and have been granted the Emergency Use Authorization (EUA) for use at the
point-of-care; however, their use is generally restricted to clinical sites because of the instrument, and/or protocol
complexity, and high cost associated with the equipment. Self-administered nasal swabs have been shown to
be an effective sample to detect COVID-19, and as a result the FDA is allowing their use as an acceptable
specimen for COVID-19 laboratory testing, paving the way for home-based COVID NAT tests.
We currently have a NIBIB project focused on the development and validation of a paper microfluidic based POC
NAT for quantifying HIV Viral load from whole blood. Here, we propose to leverage this on-going effort to develop
a COVID-19 Nucleic Acid Amplification Self Test (COAST) that can be performed at home to detect COVID-19
infections based on SARS-CoV-2 RNA. COAST is fully disposable test will detect as little as 5,000 cp/swab,
have a COGS of less than $2.50, and will have sample-to-result within 30 minutes. In this proposal, our primary
objectives are (1) optimizing and validating a sensitive and specific Recombinase Polymerase Amplification
(RPA) isothermal amplification assay for the N-gene for SARS-CoV-2 RNA with lateral flow readout and (2)
developing and evaluating the COAST home-based test with integrated sample preparation, isothermal
amplification, lateral flow read-out. RPA is a low-temperature, isothermal amplification chemistry that can
specifically detect a target with a wide range of genomic diversity and easily be integrated with LFA read-out.
COAST has a novel elution tube, self-regulating positive temperature coefficient heaters, on-paper RPA
amplification, and LFA readout. The RPA assay will be validated with de-identified SARS-CoV-2 RNA from
COVID-19 patient samples collected by UWs Virology Lab and the COAST cartridge will be evaluated using
mock nasal swabs with non-infectious targets.
COVID-19 self-testing can drastically increase total testing numbers which can improve state and federal public
health officials understanding of disease proliferation, as well as informing policy response (e.g. stay-at-home
orders, school closures, etc.) and allocation of emergency response (for example distribution of PPE or
ventilators). Self-testing can also reduce new infections by initiating prompt quarantine and public health contact
tracing, especially in the case of asymptomatic or mildly symptomatic patients.
Terms: <2019 novel coronavirus><2019-nCoV><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Anterior nares><Assay><Authorization><Authorization documentation><Bioassay><Biochemistry><Biologic Assays><Biological Assay><Biological Chemistry><Blood><Blood Reticuloendothelial System><COVID><COVID-19><COVID19><Cessation of life><Chemistry><China><Clinic><Clinical><Clinical Virology><CoV disease><Collaborations><Communicable Disease Contact Tracing><Complex><Contact Tracing><Cytolysis><Death><Detection><Detergents><Development><Devices><Diagnosis><Diagnostic><Digestion><Disease><Disorder><Emergencies><Emergency Situation><Emergency response><Ensure><Equipment><Evaluation><External Nare><Feedback><Funding><Future><Genes><Genomics><Gold><Grant><HIV><Home><Home environment><Human Immunodeficiency Viruses><Immunoassay><Individual><Infection><Infectious Disease Contact Tracing><Investigators><LAV-HTLV-III><Label><Laboratories><Lateral><Lung diseases><Lymphadenopathy-Associated Virus><Lysis><Mainland China><Membrane><Methods><Microfluidics><NIBIB><Nasal><Nasal Passages Nose><National Institute of Biomedical Imaging and Bioengineering><Non-Polyadenylated RNA><Nose><Nostril><Nucleic Acids><Paper><Patients><Permission><Policies><Polymerase><Polymerase Chain Reaction><Preparation><Proteins><Protocol><Protocols documentation><Public Health><Pulmonary Diseases><Pulmonary Disorder><Quarantine><RNA><RNA Gene Products><RNA Nucleases><RNase><RNase P><Reducing Agents><Reductants><Research Personnel><Research Resources><Research Specimen><Researchers><Resources><Respiratory Disease><Respiratory Infections><Respiratory System Disease><Respiratory System Disorder><Respiratory System, Nose, Nasal Passages><Respiratory Tract Infections><Reverse Transcription><Ribonuclease Family Protein><Ribonuclease P><Ribonucleases><Ribonucleic Acid><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Sampling><Schools><Self Administration><Self-Administered><Severe acute respiratory syndrome coronavirus 2><Specificity><Specimen><Surface><Swab><System><Temperature><Testing><Transmission><Tube><Universities><Validation><Ventilator><Viral><Viral Burden><Viral Genome><Viral Load><Viral Load result><Virus><Virus-HIV><Visit><Visual><Washington><Whole Blood><Work><Wuhan coronavirus><base><clinical research site><clinical site><cold temperature><corona virus disease><corona virus disease 2019><coronavirus disease><coronavirus disease 2019><cost><developmental><disease of the lung><disorder of the lung><improved><innovate><innovation><innovative><instrument><internal control><isolation/quarantine><low temperature><lung disorder><membrane structure><novel><particle><pathogenic virus><point of care><recombinase><response><specific biomarkers><transmission process><viral pathogen><virology><virus genome><µfluidic>